Need an investment idea? Check out S2O Stock Screener. It allows to generate a list of stocks of a particular interest in a matter of seconds!

Market Price

61.24 

-1.02 -1.6%

as of Aug 20 '19

52 Week Range:

56.74 82.46


Stock Analyzer Tutorials

S2O Stock Analyzer - General Info

General Info


type: video (mp4); length: 3:30

Demonstrates how to use Stock Analyzer, shows how to analyze a stock and explains in detail "General Info" section of the Stock Analyzer result page.

S2O Stock Analyzer - Financial Statements

Financial Statements


type: video (mp4); length: 5:10

Explains information presented in the Financial Statements section of the S2O Stock Analyzer: financial statements charts, absolute values and growth rates.

S2O Stock Analyzer - Growth Grade and Financial Ratios

Growth Grade and Financial Ratios


type: video (mp4); length: 5:09

Demonstrates how to use Growth Grade & Financial Ratios section; shows the difference between historical and year-over-year Growth Grade on the real life example.

S2O Stock Analyzer - Value Price

Value Price


type: video (mp4); length: 6:03

Demonstrates how to use Value Price (intrinsic value) and the Graham Number, MOS (margin of safety) and IRT - Investment Recovery Time; explains 3 different projection models used to compute value price - pessimistic, moderate and optimistic.

S2O Stock Analyzer - Price Charts

Price Charts


type: video (mp4); length: 8:34

Demonstrates basic rules of how to read a candlestick chart, long and short term moving averages, stochastic, MACD and relative strength (RS) charts. Explains how bull or bear market condition is computed.

General Info

Encompass Health Corporation provides facility-based and home-based post-acute healthcare services in the United States. The company operates through two segments, Inpatient Rehabilitation, and Home Health and Hospice. The Inpatient Rehabilitation segment provides specialized rehabilitative treatment on an inpatient and outpatient basis to patients who are recovering from conditions, such as stroke and other neurological disorders, cardiac and pulmonary conditions, brain and spinal cord injuries, complex orthopedic conditions, and amputations. The Home Health and Hospice segment provides home health and hospice services primarily in the Southeast and Texas. Its home health services include a range of Medicare-certified home nursing services to adult patients in need of care comprising skilled nursing, medical social work, and home health aide services, as well as physical, occupational, speech therapy, and others. This segment's hospice services comprise in-home services to terminally ill patients and their families to address patients' physical needs, including pain control and symptom management, and to provide emotional and spiritual support. As of February 21, 2019, Encompass Health Corporation operated 130 hospitals, and 278 home health and hospice agencies in 36 states and Puerto Rico. The company was formerly known as HealthSouth Corporation and changed its name to Encompass Health Corporation in January 2018. Encompass Health Corporation was founded in 1983 and is based in Birmingham, Alabama.

Financial Statements

The charts below show selected Annual and Quarterly Financial Data.

The purpose of these charts is to discover long and short term change dynamics. When numbers are growing year after year in the annual statements chart, the business become stronger and stronger and this is a good sign.

Quarterly Data Chart can be used to do a short term analysis. It makes sense to pay attention to the quarterly dynamics and do not wait for the next yearly statement. We should be alerted if we see that quarterly numbers are going down.

You can check "Annual Financial Statements" and "Quarterly Financial Statements" sections for exact numbers and growth rates.

Annual Statements

On a charts below the Line shows absolute values and the Bar chart shows Year-Over-Year Growth Rate for selected financial statement item. A consistent GROWTH is generally considered necessary to fund future growth from within a business.
NOTE: Growth Rate is not provided if either the latest period or the year-ago period contains a net loss. (source: WSJ Digest of Earnings)
TIP! move your mouse pointer over bar or a circle on any chart below to see details.

Financial Statements

Income Statement



 

Cash Flow Statement



 

Balance Sheet



 

Liquidity Ratios

Current Ratio


 

Current Ratio measures the ability to meet short term obligations. Generally accepted standard is 2 (current assets should be 2 times or 200% of current liabilities).

Quick Ratio


 

Measures immediate liquidity or the cash available to cover immediate liabilities. A safe margin would be at least 1 (100%).

Financial Leverage


 

Defined as total assets divided by total shareholders' equity. The higher the ratio, the more debt a company uses in its capital structure.

Profitability Ratios

ROA


 

Return on Assets (ROA) measures the income (profit) that is generated by the use of the assets of the business.

ROE


 

Return on Equity (ROE) is a measure of profitability that calculates how many dollars of profit a company generates with each dollar of shareholders equity. ROE is sometimes called "return on net worth."

ROIC


 

The Return on Invested Capital (ROIC) measure gives a sense of how well a company is using its money to generate returns. Some investors use this figure as a final evaluation to determine whether or not to invest in a company.

Annual Statements

Item Name Dec '08 Dec '09 Dec '10 Dec '11 Dec '12 Dec '13 Dec '14 Dec '15 Dec '16 Dec '17 Dec '18
Equity (BVPS) -13.29
-10.44
-0.91
0.71
3.05
3.65
5.12
6.99
8.17
11.56
13.33
growth rate 0.0% 0.0% 100.0% 329.6% 19.7% 40.3% 36.5% 16.9% 41.5% 15.3%
Earnings BIT 484.30
569.50
651.20
649.40
681.60
growth rate 17.6% 14.4% -0.3% 5.0%
Avg.PE 19.16
19.18
22.92
growth rate 0.1% 19.5%
ROA 11.18
3.74
43.07
7.87
6.83
9.32
7.26
4.53
5.31
5.34
5.79
growth rate -66.6% 1,051.6% -81.7% -13.2% 36.5% -22.1% -37.6% 17.2% 0.6% 8.4%
ROE 72.62
52.75
33.47
36.64
26.65
23.71
growth rate -27.4% -36.6% 9.5% -27.3% -11.0%
ROIC 17.74
19.26
13.15
8.55
9.57
9.58
10.68
growth rate 8.6% -31.7% -35.0% 11.9% 0.1% 11.5%
Cur. Ratio 0.91
1.08
1.13
1.25
2.12
1.86
1.88
1.40
1.38
1.36
0.98
growth rate 18.7% 4.6% 10.6% 69.6% -12.3% 1.1% -25.5% -1.4% -1.5% -27.9%
Quick Ratio 0.63
0.78
0.81
0.86
1.27
1.05
1.07
1.11
1.02
1.02
0.80
growth rate 23.8% 3.9% 6.2% 47.7% -17.3% 1.9% 3.7% -8.1% 0.0% -21.6%
Leverage 8.31
7.35
7.20
7.53
6.36
4.14
4.05
growth rate -11.6% -2.0% 4.6% -15.5% -34.9% -2.2%
Balance Sheet Dec '08 Dec '09 Dec '10 Dec '11 Dec '12 Dec '13 Dec '14 Dec '15 Dec '16 Dec '17 Dec '18
Acct.Receivable 323.20
410.50
443.80
472.10
467.70
growth rate 27.0% 8.1% 6.4% -0.9%
Acct.Payable 53.40
61.60
68.30
78.40
90.00
growth rate 15.4% 10.9% 14.8% 14.8%
Cur.Assets 686.60
598.70
654.50
702.20
662.10
growth rate -12.8% 9.3% 7.3% -5.7%
Total Assets 3,388.30
4,606.10
4,681.90
4,864.50
5,175.00
growth rate 35.9% 1.7% 3.9% 6.4%
Cash 66.70
61.60
40.50
54.40
69.20
growth rate -7.7% -34.3% 34.3% 27.2%
Cur.Liabilities 364.30
426.40
475.60
517.50
672.50
growth rate 17.1% 11.5% 8.8% 30.0%
Liabilities 2,590.90
3,705.70
3,614.90
3,248.20
3,356.30
growth rate 43.0% -2.5% -10.1% 3.3%
LT Debt 2,090.40
3,134.70
2,979.30
2,545.40
2,231.50
growth rate 50.0% -5.0% -14.6% -12.3%
Equity 473.20
611.40
735.90
1,152.50
1,276.70
growth rate 29.2% 20.4% 56.6% 10.8%
Common Shares 96.00
103.00
109.00
109.00
108.00
102.00
101.00
101.00
100.00
99.00
99.00
growth rate 7.3% 5.8% 0.0% -0.9% -5.6% -1.0% 0.0% -1.0% -1.0% 0.0%
Cash Flow Statement Dec '08 Dec '09 Dec '10 Dec '11 Dec '12 Dec '13 Dec '14 Dec '15 Dec '16 Dec '17 Dec '18
Capital Expenditures 170.90
128.40
177.70
225.80
254.50
growth rate -24.9% 38.4% 27.1% 12.7%
Cash Dividends 72.10
77.20
83.80
91.50
100.80
growth rate 7.1% 8.6% 9.2% 10.2%
Cash From OA 444.90
502.00
640.20
658.30
762.40
growth rate 12.8% 27.5% 2.8% 15.8%
FCF per Share 1.59
3.23
2.40
1.78
2.33
2.55
2.93
2.88
4.26
3.73
4.76
growth rate 103.1% -25.7% -25.8% 30.9% 9.4% 14.9% -1.7% 47.9% -12.4% 27.6%
Sale Purchase of Stock 26.60
26.60
26.60
26.60
growth rate 0.0% 0.0% 0.0%
FCF 153.00
334.00
260.00
233.00
252.00
254.00
257.00
328.00
403.00
412.00
491.00
growth rate 118.3% -22.2% -10.4% 8.2% 0.8% 1.2% 27.6% 22.9% 2.2% 19.2%
Income Statement Dec '08 Dec '09 Dec '10 Dec '11 Dec '12 Dec '13 Dec '14 Dec '15 Dec '16 Dec '17 Dec '18
Sales 2,374.30
3,115.70
3,642.60
3,913.90
4,277.30
growth rate 31.2% 16.9% 7.5% 9.3%
Op.Income 484.30
569.50
651.20
649.40
681.60
growth rate 17.6% 14.4% -0.3% 5.0%
IBT 386.90
395.60
482.00
496.40
493.20
growth rate 2.3% 21.8% 3.0% -0.6%
Net Income 222.00
183.10
247.60
271.10
292.30
growth rate -17.5% 35.2% 9.5% 7.8%
EPS 2.62
0.77
8.28
1.91
1.67
2.58
2.29
1.91
2.59
2.84
2.93
growth rate -70.6% 975.3% -76.9% -12.6% 54.5% -11.2% -16.6% 35.6% 9.7% 3.2%
Gross Profit 1,100.70
1,316.20
1,516.70
1,610.00
1,764.60
growth rate 19.6% 15.2% 6.2% 9.6%

Quarterly Statements

Item Name Jun '18 Sep '18 Dec '18 Mar '19 Jun '19
Earnings BIT 176.70
173.10
162.70
187.50
170.50
growth rate -2.0% -6.0% 15.2% -9.1%
Balance Sheet Jun '18 Sep '18 Dec '18 Mar '19 Jun '19
Acct.Receivable 456.60
458.00
467.70
500.60
496.00
growth rate 0.3% 2.1% 7.0% -0.9%
Acct.Payable 85.60
86.00
90.00
94.70
95.60
growth rate 0.5% 4.7% 5.2% 1.0%
Cur.Assets 671.60
638.00
662.10
682.70
844.90
growth rate -5.0% 3.8% 3.1% 23.8%
Total Assets 5,089.40
5,131.90
5,175.00
5,583.80
5,812.10
growth rate 0.8% 0.8% 7.9% 4.1%
Cash 59.00
56.90
69.20
56.10
221.70
growth rate -3.6% 21.6% -18.9% 295.2%
Cur.Liabilities 573.90
609.60
672.50
768.20
752.90
growth rate 6.2% 10.3% 14.2% -2.0%
Liabilities 3,364.20
3,311.70
3,356.30
3,694.30
3,875.50
growth rate -1.6% 1.4% 10.1% 4.9%
LT Debt 2,600.50
2,272.50
2,231.50
2,139.90
2,342.90
growth rate -12.6% -1.8% -4.1% 9.5%
Equity 1,254.90
1,318.50
1,276.70
1,314.30
1,275.90
growth rate 5.1% -3.2% 3.0% -2.9%
Common Shares 1.10
1.10
1.10
1.10
1.10
growth rate 0.0% 0.0% 0.0% 0.0%
Cash Flow Statement Jun '18 Sep '18 Dec '18 Mar '19 Jun '19
Capital Expenditures 48.90
62.70
83.00
72.30
83.50
growth rate 28.2% 32.4% -12.9% 15.5%
Cash Dividends 24.50
24.50
26.40
28.30
26.60
growth rate 0.0% 7.8% 7.2% -6.0%
Cash From OA 169.20
198.50
178.40
159.90
145.40
growth rate 17.3% -10.1% -10.4% -9.1%
Sale Purchase of Stock
growth rate
FCF 120.30
135.80
95.40
87.60
61.90
growth rate 12.9% -29.8% -8.2% -29.3%
Income Statement Jun '18 Sep '18 Dec '18 Mar '19 Jun '19
Sales 1,067.70
1,067.60
1,096.00
1,124.00
1,135.00
growth rate 0.0% 2.7% 2.6% 1.0%
Op.Income 176.70
173.10
162.70
187.50
170.50
growth rate -2.0% -6.0% 15.2% -9.1%
IBT 142.30
139.60
75.60
156.50
134.50
growth rate -1.9% -45.9% 107.0% -14.1%
Net Income 91.80
88.60
28.10
102.30
91.20
growth rate -3.5% -68.3% 264.1% -10.9%
Gross Profit 450.20
436.70
441.80
463.10
470.40
growth rate -3.0% 1.2% 4.8% 1.6%

Growth Grade & Financial Ratios

All financial ratios below are calculated based on latest annual statements available and present the most up to date snapshot of a company finances.

Growth Grade

Historical Growth Grade:

B (81.47)

YOY Growth Grade:

C (64.47)

Click on buttons above for detailed yearly growth rates.

Market Ratios

Profitability Ratios

Liquidity Ratios

Efficiency Ratios

Value Price

PE and EPS

Historical Current Forward
PE 20.72 19.68 16.75
EPS / Growth 9.9% 3.11 13.1%

Value Price & Investment Recovery Time

Read more about Stock2Own value price in Stock Market: Fundamental Analysis.

Equity Growth Rate: 24.6%

Estimates Pessimistic Moderate Optimistic My Numbers
Rate of Return 15.0%
MOS Price % 50 %
Future EPS Growth 9.9% 15.9% 15.9%
Future PE 16.75 23.07 23.07
Future EPS 7.98 13.58 13.58
Value Price
MOS %
33.05
-46.0%
77.41
26.4%
77.41
26.4%
MOS Price 16.53 38.71 38.71
IRT 10.80 8.87 8.87

Graham Number:

NOTE: The Graham Number applies only to certain types of stocks in combination with a number of other criteria.

Read more about Graham Number in Stock Market: Fundamental Analysis.

Price Chart

The functionality you are trying to reach is available to registered users only.

Login to your account or Register Now if you are not registered yet. Registration is FREE and will take only a minute.

Risk / Reward Ratios

The functionality you are trying to reach is available to registered users only.

Login to your account or Register Now if you are not registered yet. Registration is FREE and will take only a minute.